Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 2Sarcoma 1Prostatic Neoplasms 1Pain 1Ovarian Neoplasms 1Multiple Myeloma 1Mixed Dementias 1Lymphoma, Follicular 1Lung Neoplasms 1Lewy Body Disease 1Kidney Neoplasms 1Dementia, Vascular 1Dementia 1Colorectal Neoplasms 1Cognitive Dysfunction 1Breast Neoplasms 1

Interventions

nabiximols 7Morphine 7Fentanyl 7Hydromorphone 6Tapentadol 5Radiotherapy 4Prednisone 3Methadone 3Ketamine 3Duloxetine Hydrochloride 3Calcium Dobesilate 3Calcium 3Analgesia 3Acetaminophen 3cabozantinib 2Zoledronic Acid 2Surveys and Questionnaires 2Sugars 2Radiosurgery 2Pregabalin 2Pain Management 2Oxycodone 2Minocycline 2Letrozole 2Ibuprofen 2Diclofenac 2Dexamethasone 2Cryosurgery 2Calcium Gluconate 2Bupivacaine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pain × Referral and Consultation × Clear all
NCT01165281 2017-07-21

A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain

Janssen Research & Development, LLC

Phase 3 Completed
343 enrolled 15 charts

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡